0001474064-12-000017.txt : 20120201
0001474064-12-000017.hdr.sgml : 20120201
20120201161117
ACCESSION NUMBER: 0001474064-12-000017
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120120
FILED AS OF DATE: 20120201
DATE AS OF CHANGE: 20120201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nader Francois
CENTRAL INDEX KEY: 0001365343
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23272
FILM NUMBER: 12562745
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000890465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 870439579
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: (908) 450-5300
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
edgar.xml
PRIMARY DOCUMENT
X0304
4
2012-01-20
0000890465
NPS PHARMACEUTICALS INC
NPSP
0001365343
Nader Francois
550 HILLS DRIVE
BEDMINSTER
NJ
07921
1
1
0
0
President, CEO and Director
Options (right to buy)
5.71
2012-01-20
4
A
0
46313
0
A
2019-01-20
Common Stock
46313
46313
D
Represents options to purchase the Issuer's Common Stock, $0.001 par value. ("Common Stock").
On January 20, 2009, the Reporting Person was granted an option to purchase 231,563 shares of Common Stock under the Issuer's 1998 Stock Option Plan. The option was to vest and become exercisable in two equal installments on the second and third anniversary of the date of grant, with the actual number of options vesting on such dates determined based on the performance of the Common Stock relative to the performance of company stocks comprising a selected market index. The grant of the option was previously reported on the Reporting Person's Form 4 filed on January 22, 2009. On January 20, 2012, 46,313 options vested based upon the performance of the Common Stock relative to the companies in the selected market index.
/s/ Francois Nader, by Edward Stratemeier as attorney-in-fact
2012-02-01